Lucem Health
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $11M
Investors
- 6
About Lucem Health
Based in North Carolina, US, and founded in 2021, Lucem Health, Inc. operates as a healthcare firm that offers AI-powered solutions. The company was founded by its CEO, Sean Cassidy. In May 2023, Lucem Health, Inc. Lucem Health provides a remote diagnostics platform, which is a data integration and interoperability platform that is designed to improve patient care and outcomes. The company’s agnostic AI platform collects healthcare data from multiple sources, including PACS, EHRs, and other data-driven workflows. Once the data has been collected, the platform uses advanced AI and ML models to generate insights and detect diabetes, cancer, and other diseases that can be used to improve clinical workflows and patient outcomes.
Who invested in Lucem Health
6 investors across 2 rounds
See all investors in Lucem Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lucem Health
Who invested in Lucem Health?
Lucem Health has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lucem Health raised?
Lucem Health has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lucem Health last raise money?
Lucem Health's most recent round on record is a Series A, in Apr 2023.
What does Lucem Health do?
Based in North Carolina, US, and founded in 2021, Lucem Health, Inc.
Where is Lucem Health headquartered?
Lucem Health is headquartered in Raleigh, US.
Which VCs invest in companies like Lucem Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Lucem Health's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Lucem Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.